- Firm: MTS Health Investors
- Fund: MTS Health Investors IV
- Target: $300 million
- Amount raised: $155 mln
- Placement Agent: Probitas Funds Group
MTS Health Investors, the New York firm founded in 2000 by a former lead banker at Bear Stearns, has raised $155 million for its fourth buyout fund about two years after wrapping up its predecessor pool, according to a filing.
MTS Health Investors IV disclosed a date of first sale of February 12 with commitments from 24 investors. The fund is targeting $300 million. Probitas Partners is listed as the placement agent.
MTS declined to comment.
The firm’s third fund disclosed $188 million raised in February 2014 with the help of placement agents Probitas and Du Pasquier & Co.
The main executives are the same for Funds III and IV: Alexander Buzik, Curtis Lane and Oliver Moses.
Lane, whose title is senior managing director, founded MTS 16 years ago as a healthcare-focused merchant bank and private equity shop, according to the firm’s website. Previously, Lane led the healthcare investment banking unit at Bear Stearns.
Moses is the firm’s other senior managing director, while Buzik is managing director.
Among its recent deals, MTS made an undisclosed investment in HCCA International Inc, a provider of offshore clinical resources and domestic nurse staffing, according to a January announcement.
In October, it sold DNA Diagnostics Center to GHO Capital for $110 million after it paid an undisclosed sum for the company in 2008.
MTS paid an undisclosed sum for an investment in Trust Healthcare Consulting Services LLC, according to a September statement from the firm.
Action Item: For information on MTS see: www.mtspartners.com
Photo courtesy of ShutterStock